Literature DB >> 17082719

High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.

Fausto Avanzini1, Claudio Alli, Alessandro Boccanelli, Carmine Chieffo, Maria G Franzosi, Enrico Geraci, Aldo P Maggioni, Rosa M Marfisi, Gian L Nicolosi, Carlo Schweiger, Luigi Tavazzi, Gianni Tognoni, Franco Valagussa, Roberto Marchioli.   

Abstract

OBJECTIVES: Although the negative prognostic implication of a clinical history of arterial hypertension in myocardial infarction (MI) survivors is well known, the predictive role of the blood pressure (BP) regimen after MI is not well defined. The aim of this study was to investigate the prognostic significance of different BP indices in post-MI. METHODS AND
RESULTS: We evaluated the relationship between baseline systolic, diastolic, pulse and mean arterial pressure (MAP), measured by sphygmomanometry at discharge from hospital or within 3 months of an MI, and total and cardiovascular mortality in 11 116 patients enrolled in the GISSI-Prevenzione trial. Over 3.5 years of follow-up, 999 patients died, 657 of them from cardiovascular causes. Low mean and high pulse pressure were significantly associated with total and cardiovascular mortality after controlling for potential confounders in the multivariate analysis. As compared with patients with less extreme BP values, patients with MAP of 80 mmHg or less (n = 1241; 11.2%) had a 48% higher risk of cardiovascular death [95% confidenceinterval (CI) 1.16-1.87; P = 0.001] and those with pulse pressure greater than 60 mmHg (n = 958; 8.6%) had a 35% higher risk (95% CI 1.09-1.69; P = 0.007); only four subjects (0.04%) had both a high pulse pressure and a low MAP (relative risk of cardiovascular death 3.48; 95% CI 0.48-25.88; P = 0.218).
CONCLUSIONS: Our results show for the first time an additional prognostic importance of two easily measurable components of BP, definitely high pulse pressure (> 60 mmHg) and low MAP (< or = 80 mmHg), in a large sample of non-selected patients surviving MI who entered a modern programme of cardiovascular prevention.

Entities:  

Mesh:

Year:  2006        PMID: 17082719     DOI: 10.1097/01.hjh.0000251897.40002.bf

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals.

Authors:  Theodore G Papaioannou; Athanase D Protogerou; Dimitrios Vrachatis; Giorgos Konstantonis; Evaggelia Aissopou; Antonis Argyris; Efthimia Nasothimiou; Elias J Gialafos; Marianna Karamanou; Dimitris Tousoulis; Petros P Sfikakis
Journal:  Hypertens Res       Date:  2016-05-19       Impact factor: 3.872

2.  A U-shaped Association Between Blood Pressure and Cognitive Impairment in Chinese Elderly.

Authors:  Yue-Bin Lv; Peng-Fei Zhu; Zhao-Xue Yin; Virginia Byers Kraus; Diane Threapleton; Choy-Lye Chei; Melanie Sereny Brasher; Juan Zhang; Han-Zhu Qian; Chen Mao; David Bruce Matchar; Jie-Si Luo; Yi Zeng; Xiao-Ming Shi
Journal:  J Am Med Dir Assoc       Date:  2017-02-01       Impact factor: 4.669

3.  Prognostic impact of pulse pressure at admission on in-hospital outcome after primary percutaneous coronary intervention for acute myocardial infarction.

Authors:  Jun Shiraishi; Yoshio Kohno; Takahisa Sawada; Sho Hashimoto; Daisuke Ito; Masayoshi Kimura; Akihiro Matsui; Hirokazu Yokoi; Masayasu Arihara; Hidekazu Irie; Masayuki Hyogo; Takatomo Shima; Takeshi Nakamura; Satoaki Matoba; Hiroyuki Yamada; Akiyoshi Matsumuro; Takeshi Shirayama; Makoto Kitamura; Keizo Furukawa; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2012-08-28       Impact factor: 2.037

4.  Cumulative mean arterial pressure and risks of adverse cardiac and cerebrovascular events: a prospective cohort study of 53,813 adults.

Authors:  Xiao Cui; Quanhui Zhao; Junxing Yu; Ruiying Zhang; Wei Li; Lu Song; Chunhui Li; Hualing Zhao; Aiping Wu; Shouling Wu; Jun Cai
Journal:  J Hum Hypertens       Date:  2018-06-11       Impact factor: 3.012

5.  Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial.

Authors:  Per H Skoglund; Per Svensson; Joline Asp; Björn Dahlöf; Sverre E Kjeldsen; Kenneth A Jamerson; Michael A Weber; Yan Jia; Dion H Zappe; Jan Östergren
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-12-22       Impact factor: 3.738

6.  Associations Between Blood Pressure and Accelerated DNA Methylation Aging.

Authors:  Lili Xiao; Gaohui Zan; Chaoqun Liu; Xia Xu; Longman Li; Xing Chen; Zhiyong Zhang; Xiaobo Yang
Journal:  J Am Heart Assoc       Date:  2022-01-08       Impact factor: 6.106

7.  Revisiting the association of blood pressure with mortality in oldest old people in China: community based, longitudinal prospective study.

Authors:  Yue-Bin Lv; Xiang Gao; Zhao-Xue Yin; Hua-Shuai Chen; Jie-Si Luo; Melanie Sereny Brasher; Virginia Byers Kraus; Tian-Tian Li; Yi Zeng; Xiao-Ming Shi
Journal:  BMJ       Date:  2018-06-05

8.  The U-shape relationship between pulse pressure level on inpatient admission and long-term mortality in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Authors:  Huang Wei; Li Hongwei; Sun Ying; Zhang Dai; Wang Man
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-09       Impact factor: 3.738

9.  Association Between Pulse Pressure With All-Cause and Cardiac Mortality in Acute Coronary Syndrome: An Observational Cohort Study.

Authors:  Man Wang; Wen Su; Chun-Yan Jiang; Wei-Ping Li; Hui Chen; Hong-Wei Li
Journal:  Front Cardiovasc Med       Date:  2022-07-13

10.  Blood Pressure Control Has Improved in People with and without Type 2 Diabetes but Remains Suboptimal: A Longitudinal Study Based on the German DIAB-CORE Consortium.

Authors:  Ina-Maria Rückert; Jens Baumert; Michaela Schunk; Rolf Holle; Sabine Schipf; Henry Völzke; Alexander Kluttig; Karin-Halina Greiser; Teresa Tamayo; Wolfgang Rathmann; Christa Meisinger
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.